Skip to main content

Diabetic retinopathy screening barriers among Palestinian primary health care patients: a qualitative study

Abstract

Purpose

Diabetic Retinopathy (DR) screening among Palestinian diabetic patients is limited. To improve the care of our patients, we explored the barriers to DR screening with a qualitative study.

Methods

Three focus groups were conducted in the northern West Bank. Patients noncompliant with DR screening were recruited from Primary Health Care clinics. Questions were adapted from similar published studies. Informed consent was obtained and group discussions were audio recorded, transcribed, and analyzed for themes by three researchers.

Results

Most patients reported financial barriers including the costs of the exam and additional treatments, and transportation to the referral clinic. System related issues were the difficulty of getting appointments and long wait times due to inadequate numbers of ophthalmologists or screening facilities, and physicians failing to recommend screening. Personal concerns related to patients having other priorities, fears about the results, and the negative experiences of family members. Finally, cultural aspects included the stigma of wearing glasses and not doing a test for a condition without symptoms.

Conclusions

Barriers to completing retinopathy screening are multidimensional with financial, personal, educational, health system, and cultural factors. These should be taken into consideration by policy makers in order to increase the uptake and quality of service.

This is a preview of subscription content, access via your institution.

Data Availability

Data, transcripts (in Arabic language) are available for sharing upon a request to the corresponding author ZN.

References

  1. Tajunisah I, Wong P, Tan L, Rokiah P, Reddy S. Awareness of eye complications and prevalence of retinopathy in the first visit to eye clinic among type 2 diabetic patients. Int J Ophthalmol China. 2011;4:519–24.

    CAS  Google Scholar 

  2. World Health Organization. Diabetes, Key Facts. 2018.

  3. Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract. Ireland; 2019;157:107843.

  4. Lee R, Wong TY, Sabanayagam C. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis (London, England). England; 2015;2:17.

  5. Nentwich MM, Ulbig MW. Diabetic retinopathy - ocular complications of diabetes mellitus. World J Diabetes. United States; 2015;6:489–499.

  6. Alzahrani SH, Bakarman MA, Alqahtani SM, Alqahtani MS, Butt NS, Salawati EM, Alkatheri A, Malik AA, Saad K Awareness of diabetic retinopathy among people with diabetes in Jeddah, Saudi Arabia. Ther Adv Endocrinol Metab. United States; 2018;9:103–112.

  7. American Academy Of Ophthalmology. Diabetic Retinopathy - Europe.

  8. Abu-Rmeileh NME, Husseini A, Capewell S, O’Flaherty M. Preventing type 2 diabetes among Palestinians: comparing five future policy scenarios. BMJ Open. England; 2013;3:e003558.

  9. Paletinean Ministry of Health, PHIC. Health Annual Report Palestine 2018. July 2019, Nablus, Palestine.Available at http://healthclusteropt.org/admin/file_manager/uploads/files/1/Health%20Annual%20Report%20Palestine%202018.pdf. Accessed 25 Feb 2020.

  10. Retinopathy D. Information statement screening for diabetic retinopathy. San Francisco; 2014.

  11. Vashist P, Singh S, Gupta N, Saxena R. Role of early screening for diabetic retinopathy in patients with diabetes mellitus: an overview. Indian J Community Med. India; 2011;36:247–252.

  12. Sheppler CR, Lambert WE, Gardiner SK, Becker TM, Mansberger SL. Predicting adherence to diabetic eye examinations: development of the compliance withAnnual diabetic eye exams survey. Ophthalmology. United States; 2014;121:1212–1219.

  13. Cetin EN, Zencir M, Fenkci S, Akin F, Yildirim C. Assessment of awareness of diabetic retinopathy and utilization of eye care services among Turkish diabetic patients. Prim Care Diabetes. England; 2013;7:297–302.

  14. van Eijk KND, Blom JW, Gussekloo J, Polak BCP, Groeneveld Y. Diabetic retinopathy screening in patients with diabetes mellitus in primary care: incentives and barriers to screening attendance. Diabetes Res Clin Pract. Ireland; 2012;96:10–16.

  15. Lindenmeyer A, Sturt JA, Hipwell A, Stratton IM, Al-Athamneh N, Gadsby R, et al. Influence of primary care practices on patients’ uptake of diabetic retinopathy screening: a qualitative case study. Br J Gen Pract. England; 2014;64:e484–e492.

  16. Bakkar MM, Haddad MF, Gammoh YS. Awareness of diabetic retinopathy among patients with type 2 diabetes mellitus in Jordan. Diabetes Metab Syndr Obes. New Zealand; 2017;10:435–441.

  17. Alwazae M, Al Adel F, Alhumud A, Almutairi A, Alhumidan A, Elmorshedy H. Barriers for Adherence to Diabetic Retinopathy Screening among Saudi Adults. Cureus. United States; 2019;11:e6454.

  18. Kashim RM, Newton P, Ojo O. Diabetic Retinopathy Screening: A Systematic Review on Patients’ Non-Attendance. Int J Environ Res Public Health. Switzerland; 2018;15.

  19. Liu Y, Zupan NJ, Shiyanbola OO, Swearingen R, Carlson JN, Jacobson NA, et al. Factors influencing patient adherence with diabetic eye screening in rural communities: A qualitative study. PLoS One. United States; 2018;13:e0206742.

  20. Strutton R, Du Chemin A, Stratton IM, Forster AS. System-level and patient-level explanations for non-attendance at diabetic retinopathy screening in Sutton and Merton (London, UK): a qualitative analysis of a service evaluation. BMJ Open. England; 2016;6:e010952.

  21. El Khatib B, Alhawari H, Al BM. Assessment of awareness of diabetic Retinopathy among patients with diabetes mellitus attending the endocrine clinic at Jordan University Hospital. Madridge J Ophthalmol. 2017;2:17–21.

    Article  Google Scholar 

  22. Fallatah MO. Knowledge, awareness, and eye care-seeking behavior in diabetic Retinopathy: a cross-sectional study in Jeddah, Kingdom of Saudi Arabia. Ophthalmol Ther. England; 2018;7:377–385.

  23. The Coalition for Accountability and Integrity-AMAN (2018) The Coalition for Accountability and Integrity (AMAN). (2018). Towards a comprehensive health insurance scheme. Ramallah, Palestine 2018.

  24. National Center for Injury Prevention and Control D of VP. The Social-Ecological Model: A Framework for Prevention. 2020.

  25. Piyasena MMPN, Murthy GVS, Yip JLY, Gilbert C, Peto T, Premarathna M, et al. A qualitative study on barriers and enablers to uptake of diabetic retinopathy screening by people with diabetes in the Western Province of Sri Lanka. Trop Med Health. Japan; 2019;47:34.

  26. Creswell J. Qualitative inquiry & research design: choosing among five approaches: SAGE Publ; 2013.

  27. Hartnett ME, Key IJ, Loyacano NM, Horswell RL, Desalvo KB. Perceived barriers to diabetic eye care: qualitative study of patients and physicians. Arch Ophthalmol (Chicago, Ill 1960). United States; 2005;123:387–391.

  28. World Health Organization. Vision 2020: The Right To Sight. Available at https://www.who.int/blindness/partnerships/vision2020/en/. Accessed 18 Feb 2020.

  29. Graham-Rowe E, Lorencatto F, Lawrenson JG, Burr JM, Grimshaw JM, Ivers NM, Presseau J, Vale L, Peto T, Bunce C, J Francis J Barriers to and enablers of diabetic retinopathy screening attendance: a systematic review of published and grey literature. Diabet Med. England; 2018;35:1308–1319.

  30. Ajzen I, Fishbein M. The influence of attitudes on behavior. Handb attitudes 2005.

  31. Al-Alawi A, Al-Hassan A, Chauhan D, Al-Futais M, Khandekar R. Knowledge, attitude, and perception of barriers for eye care among diabetic persons registered at employee health Department of a Tertiary Eye Hospital of Central Saudi Arabia. Middle East Afr J Ophthalmol. India; 2016;23:71–74.

  32. Kitzinger J. Qualitative research. Introducing focus groups. BMJ [Internet]. BMJ Group; 1995;311:299–302. Available from: https://pubmed.ncbi.nlm.nih.gov/7633241

Download references

Acknowledgements

We would like to thank the team of Family and Community Medicine Department at AL–Najah National University (ANU) for this opportunity to conduct this study, and for their assistance. Researchers are grateful to Ministry of Health and ANU for support and facilitation our access to primary health care centers. A special thank for those who facilitated our fieldwork, and data collection, specially our colleague Dr. Layali Qaddoumi for her support in the second focus group conduction at Nablus, the research participants for cooperation, encouragement, and kindly welcome.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Affiliations

Authors

Contributions

ZN conceived of the presented idea, all authors contributed to study design, data analysis, data interpretation, the writing and revision of the abstract, and developed the manuscript drafting. TY, AA and A AF contributed to data collection. All authors have seen and approved the final version of the abstract for submission.

Corresponding author

Correspondence to Zaher Nazzal.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethics approval

Ethics approval was obtained from the Institutional Review Board of An-Najah National University, Nablus, Palestine.

Consent to participate

Verbal informed consent was obtained from all participants after explaining the aims of the study, including the use of audio recording.

Consent for publication

Not applicable.

Code availability

Not applicable

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Yahya, T., Nazzal, Z., Abdul-Hadi, AR. et al. Diabetic retinopathy screening barriers among Palestinian primary health care patients: a qualitative study. J Diabetes Metab Disord 19, 875–881 (2020). https://doi.org/10.1007/s40200-020-00575-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40200-020-00575-4

Keywords

  • Barriers
  • Diabetic retinopathy screening
  • Primary health care